Reply to thread

Message

[QUOTE="Munyaradzi Mafaro, post: 82326, member: 636"]
Biglaw drama drops as a firm raids another right before a mega merger. Paul Hastings just snagged two regulatory heavyweights, Lynn Mehler and Phil Katz, from Hogan Lovells for its D.C. life sciences team. This happens as Hogan Lovells plans its huge combination with Cadwalader.

Mehler will lead the life sciences regulatory group. Both lawyers have over six decades of combined experience guiding pharma and biotech clients through FDA rules. The hiring is a direct play to build a dominant, full-service practice for life sciences companies.

Paul Hastings chair Frank Lopez called the team's move rare. He said top regulatory talent creates a high barrier for entry in this sector. Lopez believes these hires make the firm a top destination for complex life sciences work.

Mehler spent 15 years at Hogan Lovells after 13 years working as counsel inside the FDA itself. Katz was there for 21 years, following time at Crowell & Moring and other firms. Mehler cited the energy and ambition at her new firm as a key reason for jumping.

This is part of a wider trend. Crowell & Moring added a life sciences boutique last year. Fenwick also recently moved into Boston, targeting the same sector with a team from Cooley.
[/QUOTE]

Name